Mediford offers services that support a wide range of drug research and development, from the exploratory phase to clinical testing, using the testing expertise and experience in advanced analysis accumulated through established businesses in clinical trials and non-clinical testing.
We provide non-clinical testing services for efficacy and safety of pharmaceuticals and regenerative medicine solutions at our Good Laboratory Practice (GLP)* compliant facilities. Our main laboratory services include bioanalysis services with advanced analytical techniques, such as biomarker analysis and drug concentration measurements, as well as solutions related to clinical testing.
We are committed to advancing the development of diverse and advanced treatments, through analytical technologies that support each step of the research and development journey and our services for global pharmaceutical companies and analytical laboratories.
* GLP stands for Good Laboratory Practice. It is the standard for ensuring safety and reliability in non-clinical testing of pharmaceuticals.